MiR-126 regulation of angiogenesis in age-related macular degeneration in CNV mouse model

International Journal of Molecular Sciences

Volumn 17, Issue 6, 2016, Pages

  Wang, Lei ^a   Lee, Amy Yi Wei ^b   Wigg, Jonathan P ^b   Peshavariya, Hitesh ^b   Liu, Ping ^a   Zhang, Hong ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Human microvascular endothelial cell (HMEC); MiR 126

Indexed keywords

MICRORNA 126; SPROUTY PROTEIN; SPROUTY RELATED EVH1 DOMAIN CONTAINING PROTEIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; MESSENGER RNA; MICRORNA; MIRN126 MICRORNA, MOUSE;

ADULT; AGE RELATED MACULAR DEGENERATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CAPILLARY ENDOTHELIAL CELL; CELL MIGRATION ASSAY; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LASER COAGULATION; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SUBRETINAL NEOVASCULARIZATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL MOTION; DISEASE MODEL; DRUG EFFECTS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; MACULAR DEGENERATION; METABOLISM; PATHOLOGY; RETINA NEOVASCULARIZATION; RNA INTERFERENCE;

ANIMALS; CELL MOVEMENT; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE EXPRESSION REGULATION; MACULAR DEGENERATION; MICE; MICRORNAS; RETINAL NEOVASCULARIZATION; RNA INTERFERENCE; RNA, MESSENGER; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84973315122     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17060895     Document Type: Article

References (69)

1. Ohkuma, Y.; Hayashi, T.; Sakai, T.; Watanabe, A.; Yamada, H.; Akahori, M.; Itabashi, T.; Iwata, T.; Noda, T.; Tsuneoka, H. Retinal angiomatous proliferation associated with risk alleles of ARMS2/HTRA1 gene polymorphisms in Japanese patients. Clin. Ophthalmol. 2014, 8, 143-148. [PubMed]
2. Wong, W.L.; Su, X.; Li, X.; Cheung, C.M.; Klein, R.; Cheng, C.Y.; Wong, T.Y. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob. Health 2014, 2, e106-e116. [CrossRef]
3. Jager, R.D.; Mieler, W.F.; Miller, J.W. Age-related macular degeneration. N. Engl. J. Med. 2008, 358, 2606-2617. [CrossRef] [PubMed]
4. Liu, M.M.; Chan, C.-C.; Tuo, J. Epigenetics in Ocular Diseases. Curr. Genom. 2013, 14, 166-172. [CrossRef] [PubMed]
5. Campochiaro, P.A.; Nguyen, Q.D.; Shah, S.M.; Klein, M.L.; Holz, E.; Frank, R.N.; Saperstein, D.A.; Gupta, A.; Stout, T.; Macko, J.; et al. Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular: Results of a phase I clinical trial. Hum. Gene Ther. 2006, 17, 167-176. [CrossRef][PubMed]
6. Wang, S.; Koster, K.M.; He, Y.; Zhou, Q. miRNAs as potential therapeutic targets for age-related macular degeneration. Future Med. Chem. 2012, 4, 277-287. [CrossRef] [PubMed]
7. De Nadal, E.; Ammerer, G.; Posas, F. Controlling gene expression in response to stress. Nat. Rev. Genet. 2011, 12, 833-845. [CrossRef] [PubMed]
8. Campochiaro, P.A. Ocular neovascularization. J. Mol. Med. 2013, 91, 311-321. [CrossRef] [PubMed]
9. Neely, K.A.; Gardner, T.W. Ocular neovascularization: Clarifying complex interactions. Am. J. Pathol. 1998, 153, 665-670. [CrossRef]
10. Schlenker, M.B.; Thiruchelvam, D.; Redelmeier, D.A. Intravitreal anti-vascular endothelial growth factor treatment and the risk of thromboembolism. Am. J. Ophthalmol. 2015, 160, 569-580. [CrossRef] [PubMed]
11. Van Romunde, S.H.; Polito, A.; Bertazzi, L.; Guerriero, M.; Pertile, G. Long-Term Results of Full Macular Translocation for Choroidal Neovascularization in Age-Related Macular Degeneration. Ophthalmology 2015, 122, 1366-1374. [CrossRef] [PubMed]
12. Bartel, D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281-297. [CrossRef]
13. Zampetaki, A.; Kiechl, S.; Drozdov, I.; Willeit, P.; Mayr, U.; Prokopi, M.; Mayr, A.; Weger, S.; Oberhollenzer, F.; Bonora, E.; et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 2010, 107, 810-817. [CrossRef] [PubMed]
14. Caporali, A.; Emanueli, C. MicroRNAs in postischemic vascular repair. Cardiol. Res. Pract. 2012, 2012, 486702. [CrossRef] [PubMed]
15. Ling, H.; Fabbri, M.; Calin, G.A. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat. Rev. Drug Discov. 2013, 12, 847-865. [CrossRef] [PubMed]
16. Chen, Y.; Gorski, D.H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008, 111, 1217-1226. [CrossRef] [PubMed]
17. Kuehbacher, A.; Urbich, C.; Dimmeler, S. Targeting microRNA expression to regulate angiogenesis. Trends Pharmacol. Sci. 2008, 29, 12-15. [CrossRef] [PubMed]
18. Urbich, C.; Kuehbacher, A.; Dimmeler, S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res. 2008, 79, 581-588. [CrossRef] [PubMed]
19. Fish, J.E.; Santoro, M.M.; Morton, S.U.; Yu, S.; Yeh, R.F.; Wythe, J.D.; Ivey, K.N.; Bruneau, B.G.; Stainier, D.Y.R.; Srivastava, D. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 2008, 15, 272-284. [CrossRef] [PubMed]
20. Shen, J.; Yang, X.; Xie, B.; Chen, Y.; Swaim, M.; Hackett, S.F.; Campochiaro, P. MicroRNAs regulate ocular neovascularization. Mol. Ther. 2008, 16, 1208-1216. [CrossRef] [PubMed]
21. Zhou, Q.; Gallagher, R.; Ufret-Vincenty, R.; Li, X.; Olson, E.N.; Wang, S. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23„27„24 clusters. Proc. Natl. Acad. Sci. USA 2011, 108, 8287-8292. [CrossRef] [PubMed]
22. Fish, J.E.; Srivastava, D. MicroRNAs: Opening a new vein in angiogenesis research. Sci. Signal. 2009, 2. [CrossRef] [PubMed]
23. Larsson, E.; Fredlund Fuchs, P.; Heldin, J.; Barkefors, I.; Bondjers, C.; Genové, G.; Arrondel, C.; Gerwins, P.; Kurschat, C.; Schermer, B.; et al. Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1. Genome Med. 2009, 1, 108. [CrossRef] [PubMed]
24. Chen, H.; Li, L.; Wang, S.; Lei, Y.; Ge, Q.; Lv, N.; Zhou, X.; Chen, C. Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A. Oncotarget 2014, 5, 11873-11885. [CrossRef] [PubMed]
25. Carmeliet, P.; Jain, R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473, 298-307. [CrossRef] [PubMed]
26. Casci, T.; Vinos, J.; Freeman, M. Sprouty, an intracellular inhibitor of Ras signaling. Cell 1999, 96, 655-665. [CrossRef]
27. Hacohen, N.; Kramer, S.; Sutherland, D.; Hiromi, Y.; Krasnow, M.A. Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 1998, 92, 253-263. [CrossRef]
28. Kato, R.; Nonami, A.; Taketomi, T.; Wakioka, T.; Kuroiwa, A.; Matsuda, Y.; Yoshimura, A. Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation. Biochem. Biophys. Res. Commun. 2003, 302, 767-772. [CrossRef]
29. Wakioka, T.; Sasaki, A.; Kato, R.; Shouda, T.; Matsumoto, A.; Miyoshi, K.; Tsuneoka, M.; Komiya, S.; Baron, R.; Yoshimura, A. Spred is a Sprouty-related suppressor of Ras signalling. Nature 2001, 412, 647-651. [CrossRef] [PubMed]
30. Wang, S.; Aurora, A.B.; Johnson, B.A.; Qi, X.; McAnally, J.; Hill, J.A.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 2008, 15, 261-271. [CrossRef] [PubMed]
31. Wang, S.; Olson, E.N. AngiomiRs—Key regulators of angiogenesis. Curr. Opin. Genet. Dev. 2009, 19, 205-211.[CrossRef] [PubMed]
32. Bai, Y.; Bai, X.; Wang, Z.; Zhang, X.; Ruan, C.; Miao, J. MicroRNA-126 inhibits ischemia-induced retinal neovascularization via regulating angiogenic growth factors. Exp. Mol. Pathol. 2011, 91, 471-477. [CrossRef] [PubMed]
33. Ye, P.; Liu, J.; He, F.; Xu, W.; Yao, K. Hypoxia-induced deregulation of miR-126 and its regulative effect on VEGF and MMP-9 expression. Int. J. Med. Sci. 2014, 11, 17-23. [CrossRef] [PubMed]
34. Hsieh, C.H.; Rau, C.S.; Jeng, S.F.; Lin, C.J.; Chen, Y.C.; Wu, C.J.; Lu, T.H.; Lu, C.H.; Chang, W.N. Identification of the potential target genes of microRNA-146a induced by PMA treatment in human microvascular endothelial cells. Exp. Cell Res. 2010, 316, 1119-1126. [CrossRef] [PubMed]
35. Kramer, A.; Behrens-Baumann, W. Antiseptic Prophylaxis and Therapy in Ocular Infections: Principles, Clinical Practice and Infection Control; Medical and Scientific Publishers: Canton Basel-City, Switzerland, 2002; Volume 33, p. 8.
36. Cross, M.J.; Claesson-Welsh, L. FGF and VEGF function in angiogenesis: Signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 2001, 22, 201-207. [CrossRef]
37. Adamis, A.P.; Berman, A.J. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin. Immunopathol. 2008, 30, 65-84. [CrossRef] [PubMed]
38. Ng, Y.-S.; Krilleke, D.; Shima, D.T. VEGF function in vascular pathogenesis. Exp. Cell Res. 2006, 312, 527-537. [CrossRef] [PubMed]
39. Chung, A.S.; Ferrara, N. Developmental and pathological angiogenesis. Annu. Rev. Cell Dev. Boil. 2011, 27, 563-584. [CrossRef] [PubMed]
40. Kamal, K.; Du, W.; Mills, I.; Sumpio, B.E. Antiproliferative effect of elevated glucose in human microvascular endothelial cells. J. Cell. Biochem. 1998, 71, 491-501. [CrossRef]
41. Valencia-Sanchez, M.A.; Liu, J.; Hannon, G.J.; Parker, R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006, 20, 515-524. [CrossRef] [PubMed]
42. Costa, R.; Carneiro, A.; Rocha, A.; Pirraco, A.; Falcão, M.; Vasques, L.; Soares, R. Bevacizumab and ranibizumab on microvascular endothelial cells: A comparative study. J. Cell. Biochem. 2009, 108, 1410-1417. [CrossRef] [PubMed]
43. Taniguchi, K.; Kohno, R.; Ayada, T.; Kato, R.; Ichiyama, K.; Morisada, T. Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling. Mol. Cell. Biol. 2007, 27, 4541-4550. [CrossRef] [PubMed]
44. Kuhnert, F.; Mancuso, M.R.; Hampton, J.; Stankunas, K.; Asano, T.; Chen, C.Z. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 2008, 135, 3989-3993. [CrossRef] [PubMed]
45. Zhu, N.; Zhang, D.; Xie, H.; Zhou, Z.; Chen, H.; Hu, T. Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2. Mol. Cell. Biochem. 2011, 351, 157-164. [CrossRef] [PubMed]
46. Ikeda, T.; Sawa, H.; Koizumi, K.; Yasuhara, T.; Yamasaki, T. Pars plana vitrectomy for regression of choroidalneovascularization with age-related macular degeneration. Acta Ophthalmol. Scand. 2000, 78, 460-464.[CrossRef] [PubMed]
47. Mojana, F.; Cheng, L.; Bartsch, D.U.; Silva, G.A.; Kozak, I.; Nigam, N.; Freeman, W.R. The role of abnormal vitreomacular adhesion in age-related macular degeneration: Spectral optical coherence tomography and surgical results. Am. J. Ophthalmol. 2008, 146, 218-227. [CrossRef] [PubMed]
48. Sakamoto, T.; Sheu, S.J.; Arimura, N.; Sameshima, S.; Shimura, M.; Uemura, A.; Kawano, H.; Wu, T.-T.; Kubota, T.; Sohma, R.; et al. Vitrectomy for exudative age-related macular degeneration with vitreous hemorrhage. Retina 2010, 30, 856-864. [CrossRef] [PubMed]
49. Roller, A.B.; Mahajan, V.B.; Boldt, H.C.; Abramoff, M.D.; Russell, S.R.; Folk, J.C. Effects of vitrectomy on age-Related macular degeneration. Ophthalmology 2010, 117, 1381-1386. [CrossRef] [PubMed]
50. Schulze, S.; Neugebauer, A.; Kroll, P. Appearance of age-related macular degeneration in vitrectomized and nonvitrectomized eyes: An intraindividual case study. Acta Ophthalmol. 2012, 90, 244-247. [CrossRef] [PubMed]
51. Adamis, A.P.; Shima, D.T.; Yeo, K.T.; Yeo, T.K.; Brown, L.F.; Berse, B.; Berse, B.; Damore, P.A.; Folkman, J. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 1993, 193, 631-638. [CrossRef] [PubMed]
52. Ferrara, N.; Gerber, H.P.; Le Couter, J. The biology of VEGF and its receptors. Nat. Med. 2003, 9, 669-676. [CrossRef] [PubMed]
53. Bouck, N. PEDF: Anti-Angiogenic guardian of ocular function. Trends Mol. Med. 2002, 8, 330-334. [CrossRef]
54. Dawson, D.W.; Volpert, O.V.; Gillis, P.; Crawford, S.E.; Xu, H.; Benedict, W.; Bouck, N. P. Pigment epithelium-Derived factor: A potent inhibitor of angiogenesis. Science 1999, 285, 245-248. [CrossRef][PubMed]
55. Farnoodian, M.; Kinter, J.B.; Yadranji Aghdam, S.; Zaitoun, I.; Sorenson, C.M.; Sheibani, N. Expression of pigment epithelium-derived factor and thrombospondin-1 regulate proliferation and migration of retinal pigment epithelial cells. Physiol. Rep. 2015, 3, e12266. [CrossRef] [PubMed]
56. Tombran-Tink, J. PEDF in angiogenic eye diseases. Curr. Mol. Med. 2010, 10, 267-278. [CrossRef] [PubMed]
57. Ohno-Matsui, K.; Morita, I.; Tombran-Tink, J.; Mrazek, D.; Onodera, M.; Uetama, T.; Hayano, M.; Murota, S.; Mochizuki, M. Novel mechanism for age-related macular degeneration: An equilibrium shift between the angiogenesis factors VEGF and PEDF. J. Cell. Physiol. 2001, 189, 323-333. [PubMed]
58. Barnstable, C.J.; Tombran-Tink, J. Neuroprotective and antiangiogenic actions of PEDF in the eye: Molecular targets and therapeutic potential. Prog. Retin. Eye Res. 2004, 23, 561-577. [CrossRef] [PubMed]
59. Takeyama, M.; Yoneda, M.; Gosho, M.; Iwaki, M.; Zako, M. Decreased VEGF-A and sustained PEDF expression in a human retinal pigment epithelium cell line cultured under hypothermia. Biol. Res. 2015, 48, 42. [CrossRef] [PubMed]
60. Spirin, K.S.; Saghizadeh, M.; Lewin, S.L.; Zardi, L.; Kenney, M.C.; Ljubimov, A.V. Basement membrane and growth factor gene expression in normal and diabetic human retinas. Curr. Eye Res. 1999, 18, 490-499. [CrossRef] [PubMed]
61. Autiero, M.; Waltenberger, J.; Communi, D.; Kranz, A.; Moons, L.; Lambrechts, D.; Kroll, J.; Plaisance, S.; de Mol, M.; Bono, F.; et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat. Med. 2003, 9, 936-943. [CrossRef] [PubMed]
62. Dull, R.O.; Yuan, J.; Chang, Y.S.; Tarbell, J.; Jain, R.K.; Munn, L.L. Kinetics of placenta growth factor/vascular endothelial growth factor synergy in endothelial hydraulic conductivity and proliferation. Microvasc. Res. 2011, 61, 203-210. [CrossRef] [PubMed]
63. Park, J.E.; Chen, H.H.; Winer, J.; Houck, K.A.; Ferrara, N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 1994, 269, 25646-25654. [PubMed]
64. Bai, Y.; Ma, J.X.; Guo, J.; Wang, J.; Zhu, M.; Chen, Y.; Le, Y.-Z. Müller cell—Derived VEGF is a significant contributor to retinal neovascularization. J. Pathol. 2009, 219, 446-454. [CrossRef] [PubMed]
65. Anand, S. A brief primer on microRNAs and their roles in angiogenesis. Vasc. Cell 2013, 5, 2. [CrossRef] [PubMed]
66. Han, Z.; Guo, J.; Conley, S.M.; Naash, M.I. Retinal angiogenesis in the Ins2Akita mouse model of diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 2013, 54, 574-584. [CrossRef] [PubMed]
67. Lambert, V.; Lecomte, J.; Hansen, S.; Blacher, S.; Gonzalez, M.L.; Struman, I.; Rozet, E.; de Tullio, P.; Michel Foidart, J.; Rakic, J.-M.; et al. Laser-Induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat. Protoc. 2013, 8, 2197-2211. [CrossRef] [PubMed]
68. Gilad, S.; Meiri, E.; Yogev, Y.; Benjamin, S.; Lebanony, D.; Yerushalmi, N.; Benjamin, H.; Kushnir, M.; Cholakh, H.; Melamed, N.; et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 2008, 3, e3148. [CrossRef] [PubMed]
69. Caporali, A.; Meloni, M.; Völlenkle, C.; Bonci, D.; Sala-Newby, G.B.; Addis, R.; Spinetti, G.; Losa, S.; Masson, R.; Baker, A.H.; et al. Deregulation of microRNA-503 contributes to diabetes ellmitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 2011, 123, 282-291. [CrossRef] [PubMed]